US announces allocation plan for tranche of 55 million COVID-19 vaccine doses, including 16 million to Asia
With the earlier allocation of 25 million, the Biden administration has so far pledged to distribute 80 million doses by the end of June
The vaccine was similarly effective against several variants including the one first detected in the UK, and in high-risk populations
The chance of a more deadly SAR-CoV-2 variant cropping up into existence increases the longer the virus spreads.
The White House said around 19 million will go to UN-backed program COVAX, with approximately 6 million for South and Central America, 7 million for Asia and 5 million for Africa
Gaza remains highly vulnerable to an outbreak, with less than 4 percent of its population fully or partially vaccinated
COVAX is dependent on nearly one billion doses of the AstraZeneca vaccine being made by the Serum Institute.
WHO chief Tedros Adhanom Ghebreyesus said there is already a shortfall of 190 million doses to COVAX by the end of June
Donating 20% of June-August vaccine stocks to COVAX, G7 and EU nations can close vaccine gap: UNICEF
Just 0.3 percent have been administered in the 29 lowest-income countries, home to nine percent of the world's population.
Sinopharm is a two jab inactivated vaccine and its easy storage requirements make it highly suitable for low-resource settings, the WHO said in a statement
In a preview of the discussions, Blinken said, "We won't trade shots in arms for political favours. This is about saving lives."
The Serum Institute of India has been at the forefront of producing the lower-cost AstraZeneca coronavirus shot
Indian-origin Dr Soumya Swaminathan joins international team of experts to prep for future pandemics
The UK-led Pandemic Preparedness Partnership will report to world leaders at June’s UK-hosted G7 Summit.
The revised figures comes a day after an independent panel in the US accused AstraZeneca of cherry-picking data in determining the protection offered by its vaccine
Companies traditionally pour huge amounts of money and research into drugs and vaccines, for the right to profit from them.
Ghana's food and drug authority has already authorised the use of the Indian-made vaccines as well as Russia's Sputnik V.
The first shipment from India, from the Serum Institute, will be going out to at least 25 or 30 countries, said the WHO chief scientist
Britain says more than 160 million people are at risk of being excluded from coronavirus vaccinations because they live in countries engulfed in conflict and instability
Henrietta Fore, head of UNICEF, said, "The only way out of this pandemic for any of us is to ensure vaccinations are available for all of us."
Booster shots will likely be needed, since new virus variants are spreading globally and likely to become the predominant strains.
Nepal, Bangladesh, Bhutan, Maldives received Indian vaccines under grant assistance in sync with its ‘Neighbourhood First’ policy.